TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20951301

Group type: EXPERIMENTAL
Intervention: Self-adjusting file (SAF) system with continuous irrigation
Number of subjects: 40

Group type: COMPARATOR
Intervention: Rotary nickel-titanium (NiTi) instrumentation with syringe/needle irrigation
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Modified sampling technique (S2b)
Number of subjects: 40
Study: 17394002

Group type: EXPERIMENTAL
Intervention: Household common salt solution (10 g NaCl in 1 l tap water)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Polyethylene glycol with electrolytes (PEG)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Ringer lactate
Number of subjects: 126
Study: 15856433

Group type: EXPERIMENTAL
Intervention: Clarithromycin
Number of subjects: 18
Study: 11952881

Group type: EXPERIMENTAL
Intervention: Multiple Insulin Injection (MI) therapy for 9 weeks
Number of subjects: 20

Group type: COMPARATOR
Intervention: Bedtime Insulin (BTI)
Number of subjects: 20
Study: 8557215

Group type: EXPERIMENTAL
Intervention: Type 2 fibres in the periphery of muscle fascicles
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Age-related changes in muscle fibre diameter
Number of subjects: 19
Study: 2694492

Group type: EXPERIMENTAL
Intervention: Tensilon (edrophonium) administered at 2 hours
Number of subjects: 8

Group type: COMPARATOR
Intervention: Philippine cobra antivenom (20, 50 or 100 ml) administered by constant intravenous infusion over 30 min
Number of subjects: 8
Study: 412611

Group type: EXPERIMENTAL
Intervention: Sulphur dioxide
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Sodium benzoate
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Tartrazine
Number of subjects: 272

Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (prior inhalation)
Number of subjects: 272

Group type: COMPARATOR
Intervention: Control (no reaction)
Number of subjects: 272
Study: 31236690

Group type: EXPERIMENTAL
Intervention: ICD group (n = 331)
Number of subjects: 1804

Group type: COMPARATOR
Intervention: no-ICD group (n = 1473)
Number of subjects: 1804
Study: 31961936

Group type: EXPERIMENTAL
Intervention: Intermittent enteral feedings 5 times daily at 4-hour intervals
Number of subjects: 50

Group type: COMPARATOR
Intervention: Intermittent enteral feedings 10 times daily at 2-hour intervals
Number of subjects: 50
Study: 28602319

Group type: EXPERIMENTAL
Intervention: OMS302 (Omidria [phenylephrine and ketorolac injection 1.0%/0.3%])
Number of subjects: 223

Group type: COMPARATOR
Intervention: Vehicle (balanced salt solution)
Number of subjects: 223

Group type: COMPARATOR
Intervention: Ketorolac
Number of subjects: 223

Group type: COMPARATOR
Intervention: Phenylephrine
Number of subjects: 223
Study: 27382753

Group type: EXPERIMENTAL
Intervention: Stellate ganglion block (SGB) with ropivacaine
Number of subjects: 80

Group type: COMPARATOR
Intervention: Normal saline (Control)
Number of subjects: 80
Study: 23375310

Group type: EXPERIMENTAL
Intervention: Active humidification (AH) using a heated humidifier (HH group, n = 17)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Passive humidification (PH) using a heat-and-moisture exchanger (HME group, n = 17)
Number of subjects: 34
Study: 21909493

Group type: EXPERIMENTAL
Intervention: Full-mouth scaling (FMS)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Conventional scaling and root planing (cSRP)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (cSRP)
Number of subjects: 37
Study: 19828955

Group type: EXPERIMENTAL
Intervention: Oral mesalazine (4 g) + topical mesalazine enema (1 g)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Oral mesalazine (4 g) alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mesalazine enema
Number of subjects: 0
Study: 17006600

Group type: EXPERIMENTAL
Intervention: L-methionine (active treatment)
Number of subjects: 253

Group type: COMPARATOR
Intervention: Placebo (control)
Number of subjects: 253
Study: 15609843

Group type: EXPERIMENTAL
Intervention: Combined cervical traction and electrotherapy/exercise
Number of subjects: 30

Group type: COMPARATOR
Intervention: Electrotherapy/exercise (control)
Number of subjects: 30
Study: 11726725

Group type: EXPERIMENTAL
Intervention: apoE4 phenotype
Number of subjects: 36

Group type: COMPARATOR
Intervention: apoE 3/3 phenotype
Number of subjects: 36
Study: 10052279

Group type: EXPERIMENTAL
Intervention: Short-term pulmonary rehabilitation (group I)
Number of subjects: 45

Group type: COMPARATOR
Intervention: No pulmonary rehabilitation (group II)
Number of subjects: 45
Study: 8294085

Group type: EXPERIMENTAL
Intervention: Interferon-alpha treatment
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Prednisone treatment
Number of subjects: 100

Group type: COMPARATOR
Intervention: Branched-DNA assay
Number of subjects: 100
Study: 2557304

Group type: EXPERIMENTAL
Intervention: V‐CAP plus TRT
Number of subjects: 126

Group type: COMPARATOR
Intervention: CAP plus TRT
Number of subjects: 126

Group type: COMPARATOR
Intervention: TRT (Thoracic Radiation Therapy)
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Overall treatment
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Failure patterns
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: Prognostic variables
Number of subjects: 126
Study: 4310020

Group type: EXPERIMENTAL
Intervention: Colistin sulphomethate sodium B.P. (Colomycin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pento‐N sulphomethylpolymyxin B sodium (Thiosporin)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ampicillin B.P. (Penbritin)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 0
Study: 29294858

Group type: EXPERIMENTAL
Intervention: TakeCARE video in a monitored computer lab
Number of subjects: 557

Group type: EXPERIMENTAL
Intervention: TakeCARE video at their own convenience after receiving an email link
Number of subjects: 557

Group type: COMPARATOR
Intervention: Control video about study skills
Number of subjects: 557
Study: 31781699

Group type: EXPERIMENTAL
Intervention: Immediately loaded implants with provisional resin fixed partial denture
Number of subjects: 26

Group type: COMPARATOR
Intervention: Conventionally loaded implants according to the one-stage unloaded protocol
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Both groups (immediately loaded and conventionally loaded)
Number of subjects: 26
Study: 28993007

Group type: EXPERIMENTAL
Intervention: Methotrexate
Number of subjects: 273
Study: 25966791

Group type: EXPERIMENTAL
Intervention: Balugrastim 30 mg
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Balugrastim 40 mg
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Balugrastim 50 mg
Number of subjects: 98

Group type: COMPARATOR
Intervention: Pegfilgrastim 6 mg
Number of subjects: 98
Study: 23496322

Group type: EXPERIMENTAL
Intervention: tTF‐NGR
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TMS(PEG)12 tTF‐NGR
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PEGylation of tTF‐NGR
Number of subjects: 0
Study: 20932159

Group type: EXPERIMENTAL
Intervention: Synthetic oligopeptide-coated bone mineral with collagen membrane
Number of subjects: 42

Group type: COMPARATOR
Intervention: Bone graft without peptide with collagen membrane
Number of subjects: 42
Study: 19386307

Group type: EXPERIMENTAL
Intervention: Prophylactic argon plasma coagulation (APC)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Control group (no APC)
Number of subjects: 600
Study: 17011447

Group type: EXPERIMENTAL
Intervention: Log-pEBV DNA
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: sq-T(vol)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: sq-N(vol)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: T(suv)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: N(suv)
Number of subjects: 57
Study: 15333415

Group type: EXPERIMENTAL
Intervention: etoricoxib 120 mg
Number of subjects: 225

Group type: EXPERIMENTAL
Intervention: oxycodone/acetaminophen 10/650 mg
Number of subjects: 225

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 225
Study: 11117368

Group type: EXPERIMENTAL
Intervention: RS‐127445 (500 mg)
Number of subjects: 6

Group type: COMPARATOR
Intervention: 5-HT (0.5 ng/kg/min)
Number of subjects: 6
Study: 9122731

Group type: EXPERIMENTAL
Intervention: Recombinant interferon alpha (rIFN‐alpha) as a single agent
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of rIFN‐alpha with recombinant interleukin‐2 (rIL‐2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Combination of rIFN‐alpha with combination chemotherapy regimens
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Chemoimmunotherapy using dual biologic agents
Number of subjects: 0
Study: 7849443

Group type: EXPERIMENTAL
Intervention: Immunoadsorption (IMA)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Dextran sulfate cellulose adsorption (DSA)
Number of subjects: 8
Study: 3060872

Group type: EXPERIMENTAL
Intervention: Albendazole
Number of subjects: 117

Group type: COMPARATOR
Intervention: Tiabendazole plus Flubendazole
Number of subjects: 117
Study: 30323328

Group type: EXPERIMENTAL
Intervention: Probiotics (Lactobacillus rhamnosus GG and Bifidobacterium animalis subsp lactis) for 6 months
Number of subjects: 290

Group type: COMPARATOR
Intervention: Placebo for 6 months
Number of subjects: 290
Study: 28498191

Group type: EXPERIMENTAL
Intervention: Mother Support Groups (MSGs) established in 14 clinics, meeting every 2 weeks, coordinated by volunteer HIV-positive mothers.
Number of subjects: 348

Group type: COMPARATOR
Intervention: Control arm (no MSGs).
Number of subjects: 348

Group type: EXPERIMENTAL
Intervention: Mother Support Groups (MSGs)
Number of subjects: 348
Study: 26156797

Group type: EXPERIMENTAL
Intervention: HAART
Number of subjects: 690

Group type: EXPERIMENTAL
Intervention: LNS (140 g/d)
Number of subjects: 690

Group type: EXPERIMENTAL
Intervention: HAART + LNS
Number of subjects: 690

Group type: EXPERIMENTAL
Intervention: LNS (without HAART)
Number of subjects: 690

Group type: COMPARATOR
Intervention: Control (no HAART/no LNS)
Number of subjects: 690
Study: 24910828

Group type: EXPERIMENTAL
Intervention: Intensive lifestyle intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (diabetes support and education)
Number of subjects: 0
Study: 21674263

Group type: EXPERIMENTAL
Intervention: New formulations of ziprasidone (inclusion complex with cyclodextrin, nano-suspension, semi-ordered HCl in polymer matrix)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: New formulations of ziprasidone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Commercial capsules (Geodon®) dosed in the fed state
Number of subjects: 0
Study: 18551084

Group type: EXPERIMENTAL
Intervention: 1 mg 17beta-estradiol and 2 mg drospirenone (DRSP)
Number of subjects: 47
Study: 17140165

Group type: EXPERIMENTAL
Intervention: Polyamide membrane (Polyflux 14; PA group)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Polysulfone membrane (Diacap Polysulfone HI PS 15; PS group)
Number of subjects: 14
Study: 14568511

Group type: EXPERIMENTAL
Intervention: Electrical isolation of the tongue with a latex sheet
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Short-circuiting of tongue to gingival pouch
Number of subjects: 8

Group type: COMPARATOR
Intervention: Tongue movement
Number of subjects: 8
Study: 10872014

Group type: EXPERIMENTAL
Intervention: Community intervention targeting mass media, community organizations, and education for 18 months (n=10563)
Number of subjects: 20564

Group type: COMPARATOR
Intervention: Reference status (n=9801)
Number of subjects: 20564

Group type: EXPERIMENTAL
Intervention: Community intervention (n=10563)
Number of subjects: 20564
Study: 19479398

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy with paclitaxel (200 mg/m²) and carboplatin (AUC 6) for 3 cycles (q21)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy with paclitaxel and carboplatin
Number of subjects: 23
Study: 8245523

Group type: EXPERIMENTAL
Intervention: 12.5 micrograms of rgp160-mam vaccine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 50.0 micrograms of rgp160-mam vaccine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: 200 micrograms of rgp160-mam vaccine (boosted at 18 months)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Adjuvant control
Number of subjects: 60
Study: 2875676

Group type: EXPERIMENTAL
Intervention: Lormetazepam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 0
Study: 30142768

Group type: EXPERIMENTAL
Intervention: Acupuncture and IVF‐ET combined treatment group
Number of subjects: 70

Group type: COMPARATOR
Intervention: IVF‐ET single treatment group
Number of subjects: 70
Study: 27566781

Group type: EXPERIMENTAL
Intervention: Scheduled evening sleep and enhanced lighting during night shifts
Number of subjects: 18

Group type: COMPARATOR
Intervention: Ad-lib sleep and typical lighting during night shifts
Number of subjects: 18
Study: 23764717

Group type: EXPERIMENTAL
Intervention: GlideScope (GS)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Macintosh laryngoscope
Number of subjects: 60
Study: 23057533

Group type: EXPERIMENTAL
Intervention: Injection lipolysis and hyaluronic acid dermal filler
Number of subjects: 24

Group type: COMPARATOR
Intervention: Injection lipolysis and hyaluronic acid dermal filler + non-ablative 1540 fractional laser
Number of subjects: 24
Study: 21411505

Group type: EXPERIMENTAL
Intervention: Ginseng root extract (8 g/day)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ginsenoside Re (250‐500 mg/day)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 19145924

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 16837126

Group type: EXPERIMENTAL
Intervention: Alfuzosin 10mg once a day
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 12813332

Group type: EXPERIMENTAL
Intervention: UFH-IPC (unfractionated heparin plus intermittent pneumatic compression)
Number of subjects: 107

Group type: COMPARATOR
Intervention: Enoxaparin
Number of subjects: 107

Group type: EXPERIMENTAL
Intervention: UFH-IPC
Number of subjects: 107
Study: 10906624

Group type: EXPERIMENTAL
Intervention: Atorvastatin (aggressive lipid-lowering therapy)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Angioplasty
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Quinapril (ACE inhibitor)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 9026318

Group type: EXPERIMENTAL
Intervention: Vitamin E supplementation
Number of subjects: 79

Group type: COMPARATOR
Intervention: Control group (no vitamin E supplementation)
Number of subjects: 79
Study: 1731548

Group type: EXPERIMENTAL
Intervention: Rapid administration of midazolam (0.1 mg/kg IV over 15 s)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Slow administration of midazolam (0.1 mg/kg IV over 5 min)
Number of subjects: 10
Study: 6608846

Group type: EXPERIMENTAL
Intervention: Amiodarone (1500 mg/24 hours IV + 200 mg orally every 8th hour for 3 days, then 200 mg orally 3 times daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Nifedipine (10 mg every 6th hour)
Number of subjects: 40
Study: 31251550

Group type: EXPERIMENTAL
Intervention: Clascoterone 1% BID
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Clascoterone 0.1% BID
Number of subjects: 363

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Clascoterone 0.5% BID
Number of subjects: 363

Group type: EXPERIMENTAL
Intervention: Clascoterone 1% QD
Number of subjects: 363
Study: 29126918

Group type: EXPERIMENTAL
Intervention: Community-wide intervention (CWI) promoting physical activity based on Japanese guidelines; conducted from 2013 to 2015, involving information dissemination, education, and community support.
Number of subjects: 3000

Group type: EXPERIMENTAL
Intervention: Community-wide intervention (CWI) promoting physical activity based on Japanese guidelines.
Number of subjects: 3000
Study: 26471807

Group type: EXPERIMENTAL
Intervention: LMA Proseal (PLMA)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: i-gel airway (IGA)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Both PLMA and IGA
Number of subjects: 90
Study: 24595801

Group type: EXPERIMENTAL
Intervention: S‐1 plus cisplatin and paclitaxel (2 courses)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: S‐1 plus cisplatin and paclitaxel (4 courses)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 75
Study: 22020236

Group type: EXPERIMENTAL
Intervention: Noninvasive positive pressure ventilation
Number of subjects: 40
Study: 20335484

Group type: EXPERIMENTAL
Intervention: Synchronized beta-band activity of a neuronal group
Number of subjects: 0
Study: 17343554

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) at a dosage of 0.25 mg/kg
Number of subjects: 24
Study: 16623024

Group type: EXPERIMENTAL
Intervention: Aloe vera cream applied 30 minutes before, immediately after, or both before and after UV exposure
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 12135309

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Temocapril
Number of subjects: 46

Group type: COMPARATOR
Intervention: Baseline
Number of subjects: 46
Study: 10458346

Group type: EXPERIMENTAL
Intervention: Intravesical potassium
Number of subjects: 39

Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 39
Study: 8665878

Group type: EXPERIMENTAL
Intervention: Active warming with a radiant heater (500 W)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Passive rewarming with a reflective blanket
Number of subjects: 30
Study: 2079425

Group type: EXPERIMENTAL
Intervention: Methylene diphosphonate kits (various brands)
Number of subjects: 134
Study: 7426527

Group type: EXPERIMENTAL
Intervention: Omnopon by intramuscular injection for 24 hours after operation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Salbutamol by intravenous infusion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Both groups (Omnopon and Salbutamol)
Number of subjects: 0
Study: 31271045

Group type: EXPERIMENTAL
Intervention: Occupational therapy with adjustment of the challenge-skill balance
Number of subjects: 72

Group type: COMPARATOR
Intervention: Conventional occupational therapy
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 72
Study: 26912728

Group type: EXPERIMENTAL
Intervention: Partners in Dementia Care (PDC) intervention
Number of subjects: 316
Study: 26233871

Group type: EXPERIMENTAL
Intervention: Onion peel extract (OPE) 100mg quercetin/d, 50mg quercetin twice daily; n=36 participants
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Onion peel extract (OPE)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo; n=36 participants
Number of subjects: 72
Study: 23585168

Group type: EXPERIMENTAL
Intervention: Laparoscopic Appendectomy (LA)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Conventional Appendectomy (OA)
Number of subjects: 86
Study: 21123320

Group type: EXPERIMENTAL
Intervention: Rheumatoid factor (RF) positivity
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Current smoking at baseline
Number of subjects: 0
Study: 19143950

Group type: EXPERIMENTAL
Intervention: 2 mcg.kg(‐1) IV fentanyl
Number of subjects: 100

Group type: COMPARATOR
Intervention: 2% lignocaine gel applied over the cornea of the operative eye
Number of subjects: 100
Study: 18342502

Group type: EXPERIMENTAL
Intervention: Intensive acute lymphoblastic leukaemia type chemotherapy regimen without irradiation
Number of subjects: 121
Study: 15386806

Group type: EXPERIMENTAL
Intervention: Rosiglitazone plus insulin (insulin + RSG group)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Subcutaneous insulin alone (insulin group)
Number of subjects: 23
Study: 12010890

Group type: EXPERIMENTAL
Intervention: Celecoxib 400 mg twice daily
Number of subjects: 83

Group type: EXPERIMENTAL
Intervention: Celecoxib 100 mg twice daily
Number of subjects: 83

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83
Study: 10588589

Group type: EXPERIMENTAL
Intervention: Inspiratory pressure support (PS = 4.8 +/- 0.2 cm H(2)O)
Number of subjects: 12
Study: 7872216

Group type: EXPERIMENTAL
Intervention: Exclusively breast-feeding for the first 6 months
Number of subjects: 141

Group type: COMPARATOR
Intervention: Complementing breast milk with prepared solid foods beginning at 4 months
Number of subjects: 141
Study: 2239755

Group type: EXPERIMENTAL
Intervention: Vegetarian diet
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Fish diet (predominantly vegetarian with fish consumed at least three times per week)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual meat-eating diet
Number of subjects: 0
Study: 414266

Group type: EXPERIMENTAL
Intervention: Imipramine - 25 mg t.d.s.
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Viloxazine - 50 mg t.d.s.
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control - no tablets
Number of subjects: 40
Study: 31742891

Group type: EXPERIMENTAL
Intervention: Lifestyle modifications including reducing body weight and salt intake
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lower BP treatment targets (not specifically defined)
Number of subjects: 0
Study: 31558733

Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 86

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 86
Study: 29291366

Group type: EXPERIMENTAL
Intervention: Pregnant women with intrauterine infection (n=93)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Comparison group of pregnant carriers of perinatally significant infection (n=157)
Number of subjects: 250

Group type: COMPARATOR
Intervention: Control group of healthy women (n=50)
Number of subjects: 250
Study: 26096799

Group type: EXPERIMENTAL
Intervention: Epicardial CRT
Number of subjects: 7

Group type: COMPARATOR
Intervention: Endocardial CRT
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 7
Study: 23153515

Group type: EXPERIMENTAL
Intervention: Multifaceted ergonomic intervention program (8-week duration including ergonomic training, daily exercise program, equipment modification, computer workstation assessment, typing training)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Multifaceted ergonomic intervention program
Number of subjects: 50
Study: 21663513

Group type: EXPERIMENTAL
Intervention: Melphalan and prednisone plus thalidomide (MPT)
Number of subjects: 135

Group type: COMPARATOR
Intervention: Melphalan and prednisone (MP)
Number of subjects: 135
Study: 17644552

Group type: EXPERIMENTAL
Intervention: Infliximab (5 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0